Back to User profile » Dr Peishu Liu

Papers published by Dr Peishu Liu:


Emodin Suppresses Proliferation, Migration and Invasion in Ovarian Cancer Cells by down Regulating ILK in vitro and in vivo [Retraction]

Lu JJ, Xu Y, Zhao Z, Ke XN, Wei X, Kang J, Zong X, Mao HL, Liu PS

OncoTargets and Therapy 2022, 15:851-852

Published Date: 10 August 2022

Identification of Three Potential Prognostic Genes in Platinum-Resistant Ovarian Cancer via Integrated Bioinformatics Analysis

Zhang X, Wei X, Bai G, Huang X, Hu S, Mao H, Liu P

Cancer Management and Research 2021, 13:8629-8646

Published Date: 16 November 2021

Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial Carcinoma

Lin Q, Ma X, Hu S, Li R, Wei X, Han B, Ma Y, Liu P, Pang Y

Cancer Management and Research 2021, 13:1955-1965

Published Date: 25 February 2021

Oncogenic Role of NUPR1 in Ovarian Cancer

Yu J, Zhu H, Li R, Jiang Q, Luan W, Shi J, Liu P

OncoTargets and Therapy 2020, 13:12289-12300

Published Date: 30 November 2020

Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo

Zhang X, Lu T, Ma Y, Li R, Pang Y, Mao H, Liu P

OncoTargets and Therapy 2020, 13:5069-5082

Published Date: 8 June 2020

Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer [Corrigendum]

Luan W, Pang Y, Li R, Wei X, Jiao X, Shi J, Yu J, Mao H, Liu P

OncoTargets and Therapy 2019, 12:9793-9794

Published Date: 15 November 2019

Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer

Luan W, Pang Y, Li R, Wei X, Jiao X, Shi J, Yu J, Mao H, Liu P

OncoTargets and Therapy 2019, 12:8063-8074

Published Date: 3 October 2019

Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo

Lu JJ, Xu Y, Zhao Z, Ke XN, Wei X, Kang J, Zong X, Mao HL, Liu PS

OncoTargets and Therapy 2017, 10:3579-3589

Published Date: 19 July 2017